Ambulero Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Ambulero General Information

Description

Operator of a biotechnology company intended to develop new ways to treat vascular tissue disease. The company specializes in developing cell and gene therapy products and delivering the adhesion molecule using different cell and synthetic vector technologies, enabling healthcare professionals to help heal damaged limbs significantly better than sham controls.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1951 Northwest 7th Avenue
  • Suite 600
  • Miami, FL 33136
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1951 Northwest 7th Avenue
  • Suite 600
  • Miami, FL 33136
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambulero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 13-Oct-2023 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) Cancelled Pre-Clinical Trials
2. Corporate 25-Jan-2021 $5.5M $5.5M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2019 Completed Startup
To view Ambulero’s complete valuation and funding history, request access »

Ambulero Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ambulero Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endless Frontier Labs Accelerator/Incubator
Orphinic Scientific VC-Backed Company Minority
Ventac Partners Venture Capital Minority
University of Miami University
To view Ambulero’s complete investors history, request access »

Ambulero FAQs

  • When was Ambulero founded?

    Ambulero was founded in 2019.

  • Where is Ambulero headquartered?

    Ambulero is headquartered in Miami, FL.

  • What is the size of Ambulero?

    Ambulero has 3 total employees.

  • What industry is Ambulero in?

    Ambulero’s primary industry is Drug Discovery.

  • Is Ambulero a private or public company?

    Ambulero is a Private company.

  • What is Ambulero’s current revenue?

    The current revenue for Ambulero is .

  • How much funding has Ambulero raised over time?

    Ambulero has raised $5.5M.

  • Who are Ambulero’s investors?

    Endless Frontier Labs, Orphinic Scientific, Ventac Partners, and University of Miami have invested in Ambulero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process